Image

    Cancer-Related Alopecia Risk And Treatment

    Lily Kaufman, Lilia Valentic, Lucy Rose … Brittany Dulmage
    Studysummary This opinion piece discusses strategies for managing cancer-related alopecia, emphasizing personalized approaches including scalp cooling and topical minoxidil, but it reports no new clinical results.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on link.springer.com →
    Discuss this study in the Community →

    Research cited in this study 37

    1. Oral Minoxidil for Late Alopecia in Cancer Survivors Breast Cancer Research and Treatment · 2024
    2. Retrospective Cohort Study of CDK4/6-Inhibitor-Induced Alopecia in Breast Cancer Patients Supportive Care in Cancer · 2023
    3. Retrospective Review of Oral and Topical Minoxidil for Cancer Treatment-Induced Hair Loss Archives of Dermatological Research · 2023
    4. Prevention and Treatment of Chemotherapy-Induced Alopecia: What Is Available and What Is Coming? Current Oncology · 2023
    5. The Efficacy and Safety of Oral and Topical Spironolactone in Androgenetic Alopecia Treatment: A Systematic Review Clinical, Cosmetic and Investigational Dermatology · 2023
    6. Efficacy of Low-Dose Oral Minoxidil in the Management of Anticancer Therapy-Induced Alopecia in Patients With Breast Cancer: A Retrospective Cohort Study Journal of The American Academy of Dermatology · 2022
    7. Permanent Chemotherapy-Induced Alopecia After Hematopoietic Stem Cell Transplantation Treated With Low-Dose Oral Minoxidil JAAD case reports · 2022
    8. Spironolactone in Dermatology Dermatologic Therapy · 2022
    9. Minoxidil And Its Use In Hair Disorders: A Review Drug Design Development and Therapy · 2019
    10. Tretinoin Enhances Minoxidil Response in Androgenetic Alopecia Patients by Upregulating Follicular Sulfotransferase Enzymes Dermatologic Therapy · 2019
    11. Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia JAMA Dermatology · 2019
    12. Complementary and Alternative Treatments for Alopecia: A Comprehensive Review Skin appendage disorders · 2018
    13. A Six-Month, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of a Nutraceutical Supplement for Promoting Hair Growth in Women With Self-Perceived Thinning Hair PubMed · 2018
    14. Hair Disorders in Patients with Cancer Journal of The American Academy of Dermatology · 2018
    15. Endocrine Therapy-Induced Alopecia in Patients With Breast Cancer JAMA Dermatology · 2018
    16. Management of Chemotherapy-Induced Alopecia With Scalp Cooling Journal of oncology practice · 2018
    17. Chemotherapy-Induced Alopecia Management: Clinical Experience and Practical Advice Journal of Cosmetic Dermatology · 2017
    18. Immune-Related Alopecia (Areata and Universalis) in Cancer Patients Receiving Immune Checkpoint Inhibitors British journal of dermatology/British journal of dermatology, Supplement · 2016
    19. Dermatological Adverse Events with Taxane Chemotherapy European Journal of Dermatology · 2016
    20. Alopecia in Patients Treated with Molecularly Targeted Anticancer Therapies Annals of Oncology · 2015
    21. Treatment of Permanent Chemotherapy-Induced Alopecia with Low Dose Oral Minoxidil Australasian Journal of Dermatology · 2015
    22. Cutaneous Adverse Effects of Targeted Therapies Journal of the American Academy of Dermatology · 2015
    23. Cutaneous Adverse Effects of Targeted Therapies Journal of the American Academy of Dermatology · 2015
    24. A Marine Protein-Based Dietary Supplement for Subclinical Hair Thinning/Loss: Results of a Multisite, Double-Blind, Placebo-Controlled Clinical Trial International Journal of Trichology · 2015
    25. A 3-Month, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Ability of an Extra-Strength Marine Protein Supplement to Promote Hair Growth and Decrease Shedding in Women with Self-Perceived Thinning Hair Dermatology Research and Practice · 2015
    26. Long-Term Safety and Efficacy of Bimatoprost Solution 0.03% Application to the Eyelid Margin for the Treatment of Idiopathic and Chemotherapy-Induced Eyelash Hypotrichosis: A Randomized Controlled Trial British journal of dermatology/British journal of dermatology, Supplement · 2014
    27. Efficacy of Interventions for Prevention of Chemotherapy-Induced Alopecia: A Systematic Review and Meta-Analysis International journal of cancer · 2014
    28. Safety and Efficacy of Bimatoprost Solution 0.03% Topical Application in Patients with Chemotherapy-Induced Eyelash Loss Journal of Investigative Dermatology Symposium Proceedings · 2013
    29. Alopecia With Endocrine Therapies in Patients With Cancer Oncologist · 2013
    30. Pathobiology of Chemotherapy-Induced Hair Loss The Lancet Oncology · 2013
    31. A Case of Cicatricial Alopecia Associated with Erlotinib Annals of Dermatology · 2011
    32. Chemotherapy-Induced Hair Loss PubMed · 2010
    33. Permanent Chemotherapy-Induced Alopecia: Case Report and Review of the Literature Journal of The American Academy of Dermatology · 2010
    34. Folliculitis Decalvans Associated with Erlotinib Clinical and Experimental Dermatology · 2010
    35. A Case Report of Inflammatory Nonscarring Alopecia Associated with the Epidermal Growth Factor Receptor Inhibitor Erlotinib Journal of Cutaneous Pathology · 2009
    36. Principles of Hair Cycle Control The Journal of Dermatology · 1998
    37. A Randomized Trial of Minoxidil in Chemotherapy-Induced Alopecia Journal of The American Academy of Dermatology · 1996